1 active not recruiting, 1 unknown. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
Follow Doxorubicin, Cyclophosphamide: new trials by email Literature Review of Doxorubicin, Cyclophosphamide trials Research Report on Doxorubicin, Cyclophosphamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer Doxorubicin, Cyclophosphamide, doxorubicin, Capecitabine - Breast Cancer | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 300 | 2010-03-01 | 2011-08-11 |
| Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer Carboplatin and Paclitaxel, Doxorubicin, cyclophosphamide, Doxorubicin, cyclophosphamide, carboplatin, thiotepa, cyclophosphamide - Breast Cancer | Phase 2 / Phase 3 | Active not recruiting | The Netherlands Cancer Institute | 310 | 2010-01-01 | 2022-10-12 |
Breast Neoplasms (2)
Peking Union Medical College Hospital (1) · The Netherlands Cancer Institute (1)
China (1) · Netherlands (1)
Qiang Sun, Master (1) · Sjoerd Rodenhuis, MD (1)
PMID 25937263, PMID 27325334, PMID 34037241, PMID 37689749
2009 (1)